Sunrest Lifescience Ltd

NSE: SUNREST · Other · sector

₹33.50NSE close 2026-10-23

Key numbers

Market cap₹14 cr

Price₹33.50

52w high / low₹54 / ₹30

P/E3.5xSector median 14.4x

P/B0.9xSector median 1.7x

Book value₹37.6

Dividend yield–Sector median 0.37%

ROE30.9%Sector median 13.8%

ROCE71.4%Sector median 19.6%

OPM14.4%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA1.1xSector median 8.4x

Interest cover8.1x

Current ratio2.12x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 8.1x in the last 12 months.
Net loss in 1 of the last 5 quarters.
Other income was 61% of net profit in the last 12 months.
No dividend in the last 2 financial years.
Price ₹33.50 on 2026-10-23: -38.0% from the 52-week high, +13.4% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹65.00 · low ₹30.50

Quarterly results

₹ cr	Sep 2023	Mar 2024	Sep 2024	Sep 2025	Mar 2026
Revenue	12	17	15	34	37
EBITDA	2	-1	1	3	7
OPM %	13.3%	-4.4%	5.8%	10.1%	18.4%
Other income	0	0	0	0	3
Net profit	2	-2	1	1	3
EPS (₹)	6.62	-5.30	2.71	1.57	0.79
Revenue YoY					+195.3%
Profit YoY					+69.8%

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY24	FY26	TTM
Revenue	29	71	71
EBITDA	1	10	10
Net profit	0	4	4
EPS (₹)	0.68	9.59	9.59
Revenue growth		+140.3%	–
Profit growth		+1,691.3%	–
Dividend / share (₹)	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	-22.7% (2y)	-20.5%

Balance sheet

₹ cr	FY24	FY26
Shareholders' equity	–	16
Cash & equivalents	–	3
Total assets	–	71
Fixed assets	–	8
Investments	–	0
Inventory	–	17

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY24	FY26
Cash from operations	-15	-0
Cash from investing	-0	-3
Cash from financing	15	4
Capex	0	8
Free cash flow	-15	-8

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY24	FY26
ROE %	–	25.5%
ROCE %	–	71.4%
Inventory days	–	141
Working capital days	–	170

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
SUNREST	₹14 cr	3.5x	0.9x	30.9%	71.4%	14.4%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	SUNREST
BSE code	–
ISIN	INE0PLZ01012
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-23.